TMAO could promote chronic inflammation through the activation of nuclear factor kappa B (NF−κB) and NOD-like receptor protein 3 (NLRP3) inflammasomes, which impair endothelial function and promote vascular injury, ultimately exacerbating HF [21]. Here, NLRP3 is linked to hydrops fetalis.